Insights from 2023 ASCO® Annual Meeting

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Insights from 2023 ASCO® Annual Meeting

Breast
Hematology
Lung
GI
GU
GYN
Skin
Head and Neck
Sarcoma
CNS
Basic Science

Playback speed

10 seconds

ASCO® 2023 Insights: "STAR-221 Phase 3 Trial - Domvanalimab, Zimberelimab, & Chemo vs. Nivo & Chemo in Previously Untreated, Locally Advanced, Unresectable or Metastatic GC/GEJC/EC"

By Insights from 2023 ASCO® Annual Meeting FEATURING Samuel Klempner

249 views

June 15, 2023

Comments 0

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma With Mul…

Feat. R. Alter, A. Rezazadeh

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma and Qual…

Feat. R. Alter, A. Rezazadeh

ASCO® 2023 Insights: "Post Hoc Analysis of Patients With Nonviral Et…

Insights from 2023 ASCO® Annual Meeting

A. Baron

70 views

ASCO® 2023 Insights: "KEYNOTE-859 Study of Pembro + Chemo for Advanc…

Insights from 2023 ASCO® Annual Meeting

S. Rha

147 views

ASCO® 2023 Insights: "Primary Results From the Multicenter, Randomiz…

Insights from 2023 ASCO® Annual Meeting

K. Raghav

67 views

ASCO® 2023 Insights: "Final Survival Outcomes of the Randomized Phas…

Insights from 2023 ASCO® Annual Meeting

Y. Kang

121 views

ASCO® 2023 Insights: "Phase 3 PANOVA-3 Study - TTF Therapy Concomita…

Insights from 2023 ASCO® Annual Meeting

H. Babiker

232 views

ASCO® 2023 Insights: "Phase 3 STELLAR-303 Study - XL092 in Combinati…

Insights from 2023 ASCO® Annual Meeting

J. Hecht

45 views

ASCO® 2023 Insights: "Alliance A021806 Data on Perioperative vs. Adj…

Insights from 2023 ASCO® Annual Meeting

A. Chawla, C. Ferrone

310 views

ASCO® 2023 Summary: "GI Expert Panel Discussion on Key Trials Includ…

Insights from 2023 ASCO® Annual Meeting

Y. Janjigian, S. Cytryn, S. Maron

1.6K views

ASCO® 2023 Insights: "Perioperative PD-1 Antibody Toripalimab + SOX …

Insights from 2023 ASCO® Annual Meeting

S. Yuan

34 views

ASCO® 2023 Insights: "Analysis of SUNLIGHT Trial on Trifluridine / T…

Insights from 2023 ASCO® Annual Meeting

J. Taieb

132 views

ASCO® 2023 Insights: "FGFR 2.0 in BTC - Is There a Best in Class?"

Insights from 2023 ASCO® Annual Meeting

A. Vogel

216 views

ASCO® 2023 Insights: "KRYSTAL-1 Trial - Activity & Safety of Adagras…

Insights from 2023 ASCO® Annual Meeting

S. Pant

92 views

ASCO® 2023 Insights: "Results From the Pivotal Phase 2b HERIZON-BTC-…

Insights from 2023 ASCO® Annual Meeting

S. Pant

91 views

ASCO® 2023 Insights: "STAR-221 Phase 3 Trial - Domvanalimab, Zimbere…

Insights from 2023 ASCO® Annual Meeting

S. Klempner

249 views

ASCO® 2023 Insights: "The Randomized Phase 3 CAIRO4 Study of the Dut…

Insights from 2023 ASCO® Annual Meeting

D. Van Der Kruijssen

226 views

ASCO® 2023 Insights: "Updated Results From the GALAXY Study in the C…

Insights from 2023 ASCO® Annual Meeting

E. Oki

440 views

ASCO® 2023 Insights: "A Phase 2 Basket Study of Tucatinib & Trastuzu…

Insights from 2023 ASCO® Annual Meeting

Y. Nakamura

119 views

ASCO® 2023 Insights: "The NeoCol Phase III Randomized Clinical Trial…

Insights from 2023 ASCO® Annual Meeting

L. Henrik Jensen

226 views

ASCO® 2023 Insights: "64-Month Follow-Up From CheckMate 142 - 1L Niv…

Insights from 2023 ASCO® Annual Meeting

H. Lenz

762 views

ASCO® 2023 Insights: "Phase III FIRE-4 Study - Influence of Baseline…

Insights from 2023 ASCO® Annual Meeting

S. Stintzing

876 views

ASCO® 2023 Insights: "Phase 3 ATTRACTION-5 Study - Nivo + Chemo as P…

Insights from 2023 ASCO® Annual Meeting

M. Terashima

366 views

ASCO® 2023 Insights: "Efficacy, Safety, & PROs From the Phase III IM…

Insights from 2023 ASCO® Annual Meeting

M. Kudo

281 views

ASCO® 2023 Insights: "Biomarker Analysis of 2 Zolbetuximab Phase 3 S…

Insights from 2023 ASCO® Annual Meeting

K. Shitara

508 views

ASCO® 2023 Summary: "GI Key Studies Including PROSPECT, HERIZON-BTC-…

Insights from 2023 ASCO® Annual Meeting

R. Kim, R. Mehta

3.1K views